Track topics on Twitter Track topics that are important to you
Modelling Hepato Biliary Pancreatic Organogenesis PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Modelling Hepato Biliary Pancreatic Organogenesis articles that have been published worldwide.
We have published hundreds of Modelling Hepato Biliary Pancreatic Organogenesis news stories on BioPortfolio along with dozens of Modelling Hepato Biliary Pancreatic Organogenesis Clinical Trials and PubMed Articles about Modelling Hepato Biliary Pancreatic Organogenesis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Modelling Hepato Biliary Pancreatic Organogenesis Companies in our database. You can also find out about relevant Modelling Hepato Biliary Pancreatic Organogenesis Drugs and Medications on this site too.
An 80-year-old man who had a 10×50-mm self-expandable metallic stent (SEMS) (BONA-SHIMSTENT biliary-covered; Standard SciTech Inc, Seoul, South Korea) placed for biliary obstruction due to pancreatic cancer presented with fever and jaundice. He previously underwent distal gastrectomy with Billroth II reconstruction for duodenal ulcer.
Some parameters using preoperative computed tomography (CT) have been evaluated to predict the development of pancreatic fistula (PF) after pancreaticoduodenectomy (PD). The present retrospective study evaluated the predictive value of pancreatic attenuation for PF after PD.
The present study aimed to determine the optimal timing of pancreaticoduodenectomy (PD) following preoperative biliary drainage (PBD) with consideration of postoperative morbidity and survival.
The best technique for pancreatic anastomosis after pancreaticoduodenectomy (PD) remains controversial, and the procedure for robotic PD (RPD) has not been previously reported. This study aimed to evaluate the safety and feasibility of a novel technique of pancreaticojejunostomy (PJ) for RPD.
To identify demographic characteristics, comorbidities, medical procedures, and prescription drug use that may act as predictors of underlying pancreatic cancer in acute pancreatitis.
Adjuvant chemotherapy is the standard of care for resected pancreatic ductal adenocarcinoma (PDAC). It is estimated that only 40-80% eligible patients initiate intended adjuvant chemotherapy. Completion rates are largely unknown.
Endoscopic ultrasonography (EUS)-guided bile duct stone (BDS) treatment has been developed for patients with duodenal obstruction, biliary stricture, or surgically altered anatomy. Recently, peroral transluminal video cholangioscopy (POTVCS)-guided BDS treatment via the EUS-guided biliary drainage route has been reported [1-5]. Here, we present a successful case of intrahepatic BDS extraction via the EUS-guided hepaticogastrostomy (EUS-HGS) route confirmed under direct antegrade POTVCS.
Early recognition of postoperative pancreatic fistula might decrease the risk of subsequent life threatening complications. The aim of this review was to systematically evaluate the accuracy of postoperative clinical, biochemical and radiologic variables for early recognition of clinically relevant postoperative pancreatic fistula.
The impact of preoperative biliary stenting (PBS) before pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) is controversial.
With the increasing detection of pancreatic cysts, many centers have applied endoscopic ultrasound-guided pancreatic cyst ablation (EUS-PCA), even in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas based on early promising outcomes. However, long-term effects of ethanol ablation have been rarely reported, especially regarding oncologic outcomes.
Post-operative pancreatic fistula (POPF) is a major cause of morbidity following pancreatoduodenectomy. The risk of POPF varies between individuals and thus assessment without risk adjustment is crude. However, despite the availability of numerous scores to determine risk, no study has provided a risk adjusted assessment of POPF outcomes.
Acute cholecystitis (AC) after cardiovascular surgery (CS) tends to have a serious postoperative course; however, there are few reports of AC after CS. In this study we investigated the clinical features of AC after CS.
The benefit of preoperative biliary stenting in the treatment of pancreatic ductal adenocarcinoma is controversially debated. Data from recent meta-analyses favor primary surgery for the majority of resectable pancreatic cancers. Regardless of this evidence, preoperative biliary stenting via endoscopy (EBS) is commonly performed, often before involvement of a surgeon. The goal of this study was to elucidate the association of bile duct stenting, microbiological dislocation of gut flora to the biliary compar...
Self-expandable metal stents (SEMS) are a widely accepted biliary endoprosthesis for patients with unresectable malignant biliary obstruction. Here, we identified predictors for the occlusion of SEMS in unresectable pancreatic cancer patients with biliary tract obstruction.
Pure laparoscopic versus open hemihepatectomy: a critical assessment and realistic expectations. A propensity score-based analysis of right and left hemihepatectomies from 9 European tertiary referral centers.
A stronger evidence level is needed to confirm the benefits and limits of laparoscopic hemihepatectomies.
Preoperative biliary drainage with self-expanding metal stents (SEMSs) brings liver function within acceptable range in preparation for neoadjuvant therapy (NATx) and provides relief of obstructive symptoms in patients with pancreatic cancer. We compared fully covered SEMSs (FCSEMSs) and uncovered SEMSs (UCSEMSs) for sustained biliary drainage before and during NATx.
In Japan, strategies for preoperative management of perihilar cholangiocarcinoma (PHC) have evolved over the last decade; the operative mortality has significantly reduced to
Aim of the study was to evaluate the outcomes following upfront pancreaticoduodenectomy (PD) in severely jaundiced (serum bilirubin level ≥15 mg/dl) patients with malignant distal common bile duct (CBD) obstruction.
Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
The aim of this study was to evaluate how often left-sided portal hypertension (LPH) develops and how LPH affects the long-term outcomes of patients with pancreatic cancer treated with pancreaticoduodenectomy (PD) and resection of the portal vein (PV)/superior mesenteric vein (SMV) confluence.
Procedures suitable for pre-operative localization of insulinomas are widely used, but it is unclear, whether they determine surgical success. We wanted to clarify whether preoperative localization or intra-operative ultrasound determines the success of surgically identifying and removing insulinomas.
Survival benefit of liver resection for noncolorectal liver metastases (NCRLM) remains to be defined.
The aim of the present study was to clarify the association between preoperative liver function and complications after hepatectomy.
The resection of liver tumors that involve the hepatic veins adjacent to the vena cava or hepatic hilum is technically challenging. We present our surgical techniques and the long-term outcome of 5 patients with conventionally unresectable tumors.